medigraphic.com

2013, Número 2

<< Anterior Siguiente >>

Rev Med Inst Mex Seguro Soc 2013; 51 (2)


Relación entre las enfermedades tiroideas autoinmunes y las del tejido conectivo

Barragán-Garfias JA, Zárate A

Idioma: Español
Referencias bibliográficas: 43
Paginas: e1-e5
Archivo PDF: 63.87 Kb.


RESUMEN

Si bien la función fisiológica del sistema inmunitario consiste en la defensa contra los microorganismos infecciosos, en ocasiones hay pérdida de la autotolerancia, que deriva en el desconocimiento de los autoantígenos. Las tiroidopatías son las enfermedades autoinmunes más comunes relacionadas con las glándulas exocrinas, a su vez las tiroideas autoinmunes órgano-específicas más frecuentes son la enfermedad de Graves-Basedow y la tiroiditis de Hashimoto. Se ha observado que estas tienen una mayor prevalencia en pacientes con enfermedades del tejido conectivo (autoinmunes sistémicas) tales como el síndrome de Sjögren, artritis reumatoide, el lupus eritematoso sistémico y las miopatías sistémicas. De igual forma, se ha identifi cado una mayor prevalencia de anticuerpos antinucleares y de anticuerpos contra antígenos extraídos del núcleo en pacientes con alguna enfermedad tiroidea autoinmune. Dado el alto porcentaje de pacientes con enfermedades tiroideas subclínicas, es recomendable que en los pacientes con enfermedades del tejido conectivo y datos de hipo o hipertiroidismo se solicite anticuerpos antitiroglobulina y antiperoxidasa.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Abbas A. Inmunología celular y molecular. Sexta edición. Espańa: Elsevier; 2008.

  2. Biró E, Szekanecz Z, Czirják L, et al. Association of systemic and thyroid autoinmune diseases. Clin Rheum. 2006;25(2): 240-5.

  3. Bernet V, Burman K. Autoimmune thyroid disease. En: Rich RR, Fleisher TA, Schwartz BD, Shearer WT, Strober W, editores. Clinical immunology: principles and practice. St. Louis, MO: Mosby; 1996. p. 1482-502.

  4. Marinó M, Ricciardi R, Pinchera A, et al. Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Endocrinol Metab. 1997;82(2):438-43.

  5. Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev. 1994;15(6):788-830.

  6. Tektonidou MG, Anapliotou M, Vlachoyiannopolous P, et al. Presence of systemic disorders in patients with autoimmune thyroid disease. Ann Rheum Dis. 2004;63:1159-61.

  7. Masuko-Hongo K, Kato T. The association between autoimmune thyroid diseases and rheumatic diseases: a review. Nihon Rinsho. 1999;57(8):1873-7.

  8. Langton JE, Brent GA. Nonthyroidal th yroidal illness syndrome: evaluation of thyroid function in sick patients. Endocrinol Metab Clin North Am. 2002;31(1):159-72.

  9. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348(26):2646-55.

  10. Corapcioglu D, Tonyukuk V, Kiyan M, et al. Relationship between thyroid autoimmunity and Yersinia enterocolitica antibodies. Thyroid. 2002;12(7):613-7.

  11. Girschick HJ, Guilherme L, Inman RD, et al. Bacterial triggers and autoimmune rheumatic diseases. Clin Exp Rheumatol 2008;26(I Suppl 48):S12-7.

  12. Yamato E, Ikegami H, Kawaguchi Y, et al. Insulindependent diabetes mellitus associated with autoimmune thyroiditis and rheumatoid arthritis. Am J Med Sci. 1997;313(1):64-6.

  13. Molteni M, Barili M, Eisera N, et al. Anti-thyroid antibodies in Italian scleroderma patients: association of anti-thyroid peroxidase antibodies with HLADR15. Clin Exp Rheumatol. 2000;15(5):529-34.

  14. Chistiakov DA, Turakulov RI. CTLA-4 and its role in autoimmune thyroid disease. J Mol Endocrinol. 2003;31(1):21-36.

  15. Toussirot E, Saas P, Deschamps M, et al. Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity. Arthritis Res Ther. 2009;11(4):101-12.

  16. Danoy P, Wei C, Johanna H, et al. Association of variants in MMEL1 and CTLA4 with rheumatoid arthritis in the Han Chinese population. Ann Rheum Dis. 2011;70(10):1793-7.

  17. Cunninghame Graham DS, Wong AK, McHugh NJ, et al. Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study. Hum Mol Genet. 2006;15(21):3195-205.

  18. Bjornvold M, Undlien DE, Joner G, et al. Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes. Diabetologia. 2008;51(4):589-96.

  19. Salliot C, Dawidowicz K, Lukas C, et al. PTPN22R620W genotype-phenotype correlation analysis and gene-environment interaction study in early rheumatoid arthritis: results from the ESPOIR cohort. Rheumatology. 2001;50(10):1802-8.

  20. Eliopoulos E, et al. Association of the PTPN22 R620W polymorphism with increased risk for SLE in the genetically. Lupus. 2011;20(5):501-6.

  21. Cho JH, Grengersen PK. Genomics and the mutifactiorial nature of human autoimmune disease. N Engl J Med. 2011;365(17):1612-23.

  22. Lazarus JH, Parkes AB, Premawardhana LD. Postpartum thyroiditis. Autoimmunity. 2002;35(3):169-73.

  23. Petranyi G, Dobozy A, Gergely P, editores. Klinikai immunológia. Budapest: Medicina; 2000.

  24. Streetman DD, Khanderia U. Diagnosis and treatment of Graves disease. Ann Pharmacother. 2003; 37(7-8):1100-9.

  25. Panzer C. Rapid progression for severe hyperthyroid Graves disease. J Clin Endocrinol Metab 2004;89(5):2142-4.

  26. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classifi cation criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569-81.

  27. Drosos A. Epidemiology of rheumatoid arthritis. Autoimmun Rev. 2004;(3 Suppl 1):S20-2.

  28. Turesson C, O´Fallon W, Crowson C, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoide arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62(8):722-7.

  29. Prochorec-Sobieszek M, Wagner T, Loukas M, et al. Histopathological and immunohistochemical analysis of lymphoid follicles in labial salivary glands in primary and secondary Sjögren syndrome. Med Sci Monit. 2004;10(4):BR115-21.

  30. Vitali C, et al. Classifi cation criteria for Sjögren syndrome; a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis. 2002;61(6):554-8.

  31. García-Carrasco M, Ramos-Casals M, Rosas J, et al. Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine. 2002;81(4):270-80.

  32. Matsumoto T, Morizane T, Aoki Y, et al. Autoimmune hepatitis in primary Sjögren syndrome: pathological study of the livers and labial salivary gonadism 17 patients. Pathol Int. 2005;55(2):70-6.

  33. Ramos-Casals M, Anaya JM, García-Carrasco M, et al. Cutaneous vasculitis primary Sjögren syndrome: classifi cation and clinical signifi cance of 52 patients. Medicine. 2004;83:96-106.

  34. Pérez B, et al. Autoimmune thyroid disease in primary Sjögren´s syndrome. Am J Med. 1995;99(5):480-4.

  35. Hansen BU, Ericsson UB, Henricsson V, et al. Autoimmune thyroiditis and primary Sjögren´s syndrome: clinical and laboratory evidence of the coexistence of the two disease. Clin Exp Rheumatol. 1991;9(2):137-41.

  36. Coll J, Anglada J, Tomas S, et al. High prevalence of subclinical Sjögren syndrome features in patients with autoimmune thyroid disease. J Rheumatol. 1997; 24(9):1719-24.

  37. Gladman DD, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996;39(3):363-9.

  38. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum. 1995;38(2):274-83.

  39. Arbuckle MR, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003;349(16):1526-33.

  40. Bredella MA, Steinbach LS, Morgan S, et al. MRI of the sacroiliac joints in patients with moderate to severe ankylosing spondylitis. Am J Roentgenol. 2006;187(6):1420-6.

  41. Ho PY, Barton A, Worthington J, et al. Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated infl ammatory arthritis. Ann Rheum Dis. 2008;67(5):677-82.

  42. Orchard TR, Thiyagaraja S, Welsh KI, et al. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of infl ammatory bowel disease. Gastroenterology. 2000;118(2):274-8.

  43. Peluso R, Lupoli GA, Del Puente A, Iervolino S, Bruner V, Lupoli R, et al. Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. J Rheumatol. 2011;38(7):1371-7.




2020     |     www.medigraphic.com